SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001520138-17-000286
Filing Date
2017-08-24
Accepted
2017-08-23 18:35:49
Documents
45
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD ENDED JUNE 30, 2017 bivi-20170630_10k.htm 10-K 525628
2 EXHIBIT 31.1 bivi-20170630_10kex31z1.htm EX-31.1 12500
3 EXHIBIT 32.1 bivi-20170630_10kex32z1.htm EX-32.1 6187
4 GRAPHIC image_001.jpg GRAPHIC 12743
5 GRAPHIC image_002.jpg GRAPHIC 2788
  Complete submission text file 0001520138-17-000286.txt   1871344

Data Files

Seq Description Document Type Size
6 XBRL LABEL FILE bivi-20170630_lab.xml EX-101.LAB 154808
7 XBRL PRESENTATION FILE bivi-20170630_pre.xml EX-101.PRE 110545
8 XBRL SCHEMA FILE bivi-20170630.xsd EX-101.SCH 19489
9 XBRL INSTANCE FILE bivi-20170630.xml EX-101.INS 243902
10 XBRL CALCULATION FILE bivi-20170630_cal.xml EX-101.CAL 28359
11 XBRL DEFINITION FILE bivi-20170630_def.xml EX-101.DEF 32341
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-55292 | Film No.: 171047928
SIC: 2834 Pharmaceutical Preparations